Skip to content

Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Prospective, Multicenter, Randomized Controlled Clinical Study of Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06713031
Enrollment
400
Registered
2024-12-03
Start date
2024-12-10
Completion date
2026-10-31
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Neck of Femur

Keywords

cannulated compression screws with iliac bone graft, Medial enhancement technique with iliac bone graft

Brief summary

A prospective, multi-center, randomized controlled study was conducted to validate the safety and effectiveness of employing the medial augmentation technique (incorporating the dynamic condylar screw and medial support plate) supplemented with bone grafting for the treatment of old femoral neck fractures.

Interventions

PROCEDUREcannulated compression screws + iliac bone graft

Using cannulated compression screws + iliac bone graft technique to treat old femoral neck fractures

PROCEDUREDCS + medial support plate + iliac bone graft

Using DCS + medial support plate + iliac bone graft technique to treat old femoral neck fractures

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>= 18 years, gender not specified; 2. Patients with femoral neck fractures who have not undergone surgery for more than 3 weeks, or patients with persistent non-union following internal fixation of femoral neck fractures; 3. Have indications for internal fixation surgery for femoral neck fractures and are able to tolerate the surgery; 4. Participants or their legal representatives are informed about the nature of this study and agree to participate.

Exclusion criteria

1. Participants who have not reached the primary endpoint of other drug, biological agent, or medical device clinical trials prior to enrollment; 2. Known history of hypersensitivity to one or more implanted materials by the patient; 3. Judged by the investigator as physically frail or unable to tolerate surgery due to other systemic diseases; 4. Active infectious foci in the hip joint or other parts of the body, as judged by the investigator; 5. Diagnosed with metabolic bone disease, radiation-induced bone disease, etc.; 6. Severe hip contracture deformity or severe muscle weakness that has been immobilized in functional position for a long time and painless; 7. Suffering from inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.; 8. Patients who lack the mental capacity or understanding to meet the requirements of participating in the study, or are difficult to cooperate with; 9. Other situations where the investigator deems the participant unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Fracture healing rate1 year

Secondary

MeasureTime frameDescription
Femoral head necrosis1 yearCommonly used imaging tools include X-rays, Magnetic Resonance Imaging (MRI), and Computerized Tomography (CT). X-rays are the most commonly employed assessment tool, capable of displaying the morphology of the femoral head and whether the bone structure is normal. MRI and CT can provide more detailed images, aiding in the determination of the extent and range of femoral head necrosis.
Harris score1 yearThe Harris Score (Harris Hip Score, HHS) is a widely used scale for evaluating hip joint function and patient quality of life, often applied to assess the outcomes of hip replacement surgery or other treatments for hip joint diseases. It covers four main aspects: pain level, functional activity, joint range of motion, and hip joint deformity. The total score ranges from 0 to 100, with 100 being the best possible condition, indicating complete normalcy of hip joint function.
VAS score1 yearThe VAS score (Visual Analog Scale) is a commonly used tool for quantifying pain assessment that is suitable for measuring various degrees of pain. The VAS score typically employs a straight line 10 centimeters long (or an equivalent visual scale), with each end marked as No Pain and Most Intense Pain respectively. A straight line 10 centimeters long (or an equivalent visual scale) is often utilized, with each end labeled as No Pain and Most Intense Pain.
Complications1 yearFocusing on perioperative complications in patients, indications and symptoms of incision infection, including redness, swelling, drainage, and fever, should be carefully monitored. The incidence and severity of infection cases should be recorded and analyzed to evaluate the risk factors for postoperative infection and the effectiveness of preventive strategies. Unplanned reoperations should be recorded, including cases of primary surgery failure, development of complications, or other situations necessitating further surgical intervention. Detailed records of the causes, timing, and outcomes of reoperations will help evaluate the reliability of surgical techniques and internal fixation devices. Additionally, other postoperative complications, such as femoral head necrosis, repositioning of fracture ends, fixation loosening and breakage, should be meticulously recorded and observed.

Countries

China

Contacts

Primary ContactWei Zhang
bszw@hotmail.com+8612409252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026